✦ LIBER ✦

Uncommon or Delayed Adverse Events Associated With Imatinib Treatment for Chronic Myeloid Leukemia

✍ Scribed by Rishard Salie; Richard T. Silver

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment for chronic myeloid

✍ Guoqing Wei; Shamudheen Rafiyath; Delong Liu 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 298 KB

Treatment with dasatinib for chronic mye

✍ Harbaum, Lars; Marx, Andreas; Goekkurt, Eray; Schafhausen, Philippe; Atanackovic 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 259 KB

Management of adverse events associated

✍ Jabbour, E; Deininger, M; Hochhaus, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Management of adverse events associated

✍ Jabbour, E; Deininger, M; Hochhaus, A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

Dasatinib: From Treatment of Imatinib-Re

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Treatment options for patients with chro

✍ Brady Stein; B. Douglas Smith 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 898 KB